The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease
UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research
Balky sign-ups complicate virus vaccinations for blind, deaf
Unable to see, Carla McQuillan typically uses a program that converts the letters on a screen into audible words when
Belgium pauses re-opening plans as virus infections mount
Belgian Prime Minister Alexander De Croo said Friday that the country faces a few “crucial weeks” as the number of
SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion
A recent study by researchers in Switzerland found that the Pfizer-BioNTech mRNA vaccine had limited efficacy in identifying mutated receptor-binding
Coronaviruses may be vulnerable to ultrasound vibrations, study suggests
The coronavirus' structure is an all-too-familiar image, with its densely packed surface receptors resembling a thorny crown. These spike-like proteins
Why does convalescent plasma therapy for severe COVID-19 show mixed success?
Treatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
Why does convalescent plasma therapy for severe COVID-19 show mixed success?
Treatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
What is a protective neutralizing antibody titer against SARS-CoV-2 infection?
Caused by the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic continues
What is a protective neutralizing antibody titer against SARS-CoV-2 infection?
Caused by the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic continues
Natural virus-induced immunity protective against UK and South African SARS-CoV-2 variants in hamster study
As new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge, fueling the continued spread of